FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Aladdin Healthcare Technologies SE Stock AnalysisComprehensive stock analysis for Aladdin Healthcare Technologies SE (ALDNF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisALDNF
ALDNF
Aladdin Healthcare Technologies SE
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ALDNF
Home🔹Stocks🔹Aladdin Healthcare Technologies SE

Aladdin Healthcare Technologies SE

ALDNF•OTC

Aladdin Healthcare Technologies SE

ALDNF•OTC
Market cap
$160.41K
Sentiment

Your view on ALDNF

Mkt Cap
$160.41K
Sentiment
Your view
ALDNF
Aladdin Healthcare Technologies SE
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ALDNF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Aladdin Healthcare Technologies SE

Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Wade Menpes-Smith
Headquarters
Unter den Linden 10, Berlin, DE
Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Wade Menpes-Smith
Headquarters
Unter den Linden 10, Berlin, DE
Description

Aladdin Healthcare Technologies SE, through its subsidiary, Aladdin Healthcare Technologies Ltd, develops software solutions for the storage and management of health information using blockchain technology. It specializes in technologies, such as blockchain, machine learning, and artificial intelligence. The company engages in the research and development of Artificial Intelligence Early Diagnosis, an artificial intelligence powered data analysis platform for brain imaging; Health Risk Assessment platform that assesses the risk of cardiovascular, as well as diabetes and kidney related diseases in patients; and Artificial Intelligence assisted Drug Discovery platform to identify various small molecule drug compounds with multiple age-related diseases, including Alzheimer's, Parkinson's, and SARS-CoV-2. It uses blockchain, machine learning, artificial intelligence, and advanced predictive data analytics for the early diagnosis of chronic diseases. The company was founded in 2014 and is based in Berlin, Germany.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News